ANTX
#3601
AN2 Therapeutics, Inc. - Common Stock
5.4 9 USD
-0.02%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-1.61%
Variación mensual
+1.86%
Variación en los últimos 6 meses
+399.09%
Cambio anual
+390.18%
Cierres anteriores
5.5 8
Open
5.4 8
Mínimo
5.4 8
Máximo
5.5 0
Volumen
12
Financials
- Market Capitalization 207.17 M
- Employee 21
- Founded 2017
- CEO N/A
- Website www.an2therapeutics.com
- Headquarter Delaware, United States
- FIGI BBG00QYLYBK4
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 3598 |  ORMP Oramed Pharmaceuticals Inc. - Common Stock | 5.02 USD | -0.20% | +4.15% | +22.14% | +134.58% | 208.82 M USD | ||
| 3600 |  PLX Protalix BioTherapeutics, Inc. Common Stock | 2.59 USD | +2.37% | +8.37% | +8.82% | -11.30% | 208.68 M USD | ||
| 3605 |  PEPG PepGen Inc. - Common Stock | 2.99 USD | -2.92% | -6.85% | +68.93% | +155.56% | 207.09 M USD | ||
| 3606 |  CHRS Coherus Oncology, Inc. - Common Stock | 1.31 USD | -7.09% | -5.76% | -7.75% | -18.63% | 202.40 M USD |